This announcement is a separate document:
天大藥業：終止收購目標公司的50.1%股權及與賣方之合作協議之主要交易
TIANDA PHARMA: TERMINATION OF MAJOR TRANSACTION IN RELATION TO ACQUISITION OF 50.1% EQUITY INTERESTS IN THE TARGET COMPANY AND THE COOPERATION AGREEMENT WITH THE VENDOR
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.